How Tumor-on-a-Chip Technology Is Transforming Cancer Treatment and Drug Testing

Episode notes

What if the tools we use to test cancer drugs don’t behave like human tumors at all? That’s the question that pushed Ghazaleh Madani , CEO and co-founder of CanChips , to build one of the most compelling innovations in oncology today: tumor-on-a-chip platforms that replicate human tumor biology with unprecedented accuracy. In this episode, we explore how microfluidics, 3D co-cultures, endothelial layers, and real-time biosensing combine to replace outdated 2D cultures and reduce reliance on animal models. The result: faster, more predictive cancer drug testing — and a pathway toward truly personalized oncology. Our sponsor: Exclusive Black Friday offer – NordStellar x Startuprad.io. NordStellar, developed by the team behind NordVPN, gives startups and scaleups real-time insights into leaked credentials, darknet threats, and unprotected assets – before attackers can exploit them. Get 20% off with code blackfriday20 at nordstellar.com/startupradio. Offer valid until December 10, 2025 – protect your business before your data is offered for sale on the darknet. NordStellar – Know what attackers know. Act first.